Literature DB >> 7002191

Hepatotoxicity of mild analgesics.

L F Prescott.   

Abstract

1 Hepatotoxicity is rare when mild analgesics are used in normal therapeutic doses. 2 The potential of aspirin and salicylates to cause hepatotoxicity has been only recently recognized. 3 Salicylate hepatitis is often asymptomatic, and may only be revealed by finding elevated levels of aminotransferases. 4 Most cases have occurred in children or young adults with connective tissue diseases, who take high doses of salicylates for long periods. 5 Hepatic injury is not recognized as a complication of acute aspirin poisoning. 6 Following overdosage of paracetamol, a toxic intermediate metabolite causes acute hepatic necrosis which may be fatal. 7 Cysteamine, methionine and N-acetylcysteine confer protection against this severe liver damage, but the time between overdosage and treatment is critical. 8 The chronic therapeutic use of paracetamol should be considered a potential but very rare cause of active chronic hepatitis. 9 There is no clear evidence of phenacetin hepatotoxicity in man. 10 Phenylbutazone may cause liver injury and other analgesics can cause hypersensitivity reactions in which the liver is involved.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002191      PMCID: PMC1430182          DOI: 10.1111/j.1365-2125.1980.tb01825.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  39 in total

1.  ACUTE POISONING WITH BUTAZOLIDIN (R) (PHENYLBUTAZONE).

Authors:  J JUUL
Journal:  Acta Paediatr Scand       Date:  1965-09

2.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

3.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.

Authors:  J R Mitchell; D J Jollow; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

4.  Acute liver necrosis following overdose of paracetamol.

Authors:  D G Davidson; W N Eastham
Journal:  Br Med J       Date:  1966-08-27

5.  Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters.

Authors:  B Portmann; I C Talbot; D W Day; A R Davidson; I M Murray-Lyon; R Williams
Journal:  J Pathol       Date:  1975-11       Impact factor: 7.996

6.  Hepatoxicity with encephalopathy associated with aspirin therapy in rheumatoid arthritis.

Authors:  M H Ulshen; R J Grand; J D Crain; E W Gelfand
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

7.  Chronic salicylate administration in juvenile rheumatoid arthritis: aspirin "hepatitis" and its clinical significance.

Authors:  J G Schaller
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

8.  Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning.

Authors:  L F Prescott; G R Sutherland; J Park; I J Smith; A T Proudfoot
Journal:  Lancet       Date:  1976-07-17       Impact factor: 79.321

9.  Acute liver failure and encephalopathy (Reye's syndrome?) during salicylate therapy.

Authors:  M Sillanpää; A L Mäkelä; A Koivikko
Journal:  Acta Paediatr Scand       Date:  1975-11

10.  Chronic hepatic inflammation and fibrosis due to low doses of paracetamol.

Authors:  H L Bonkowsky; G H Mudge; R J McMurtry
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

View more
  14 in total

1.  Paracetamol use and lowered risk of acute kidney injury in patients with rhabdomyolysis.

Authors:  Maxime Desgrouas; Thierry Boulain
Journal:  J Nephrol       Date:  2021-01-05       Impact factor: 3.902

2.  Protective effects of 2,4-dihydroxybenzophenone against acetaminophen-induced hepatotoxicity in mice.

Authors:  Yue-Ying He; Bao-Xu Zhang; Feng-Lan Jia
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

3.  Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.

Authors:  Venkat R Pannala; Kalyan C Vinnakota; Kristopher D Rawls; Shanea K Estes; Tracy P O'Brien; Richard L Printz; Jason A Papin; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-08       Impact factor: 4.219

4.  The clinical assessment of analgesic drugs.

Authors:  D W Littlejohns; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

5.  Common mistakes, negligence and legal offences in paediatric dentistry: a self-report.

Authors:  M Ashkenazi; E Bijaoui; S Blumer; M Gordon
Journal:  Eur Arch Paediatr Dent       Date:  2011-08

6.  Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity.

Authors:  Mohamed A Abdelmegeed; Kwan-Hoon Moon; Chi Chen; Frank J Gonzalez; Byoung-Joon Song
Journal:  Biochem Pharmacol       Date:  2009-08-04       Impact factor: 5.858

7.  Roles of lipoxin A4 in preventing paracetamol-induced acute hepatic injury in a rabbit model.

Authors:  Jian Xia; Xian-Long Zhou; Yan Zhao; You-Qing Zhu; Shan Jiang; Shao-Zhou Ni
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

8.  Comparison of a traditional paracetamol medication and a new paracetamol/paracetamol-methionine ester combination.

Authors:  L A Skoglund; P Skjelbred
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice.

Authors:  Laura Zanobbio; Marco Palazzo; Silvia Gariboldi; Giuseppina F Dusio; Diego Cardani; Valentina Mauro; Fabrizio Marcucci; Andrea Balsari; Cristiano Rumio
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

10.  Analgesic-associated nephropathy.

Authors:  A Schwarz
Journal:  Klin Wochenschr       Date:  1987-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.